Biocon: There's a myth that cutting prices is unprofitable

Biocon says it wants to lower the cost of insulin for patients. Kiran Mazumdar Shaw of Biocon says she believes in producing a high volume of products to sell at a low cost and that that won't compromise on profitability.
Tue, Oct 15 20194:49 AM EST